In order to ensure 2023 billing, testing must be activated before the end of the year, or within 30 days of proband sample collection (if sample was collected in 2023). For Exome, Genome, or Xpanded testing, if you do not expect parental samples to be received in time for testing to be activated with 2023 billing, please contact us at email@example.com to determine how to proceed.
Extensive and flexible hereditary cancer testing options to aid in personalized medical management.
Our expertise in hereditary cancer began over a decade ago, founded by cancer-focused genetic counselors and molecular geneticists who wanted to lead genetic testing in clinical oncology. Today, we’re known for our expertise utilizing a variety of technologies and specimen types, our dedicated clinical service liaison genetic counseling team, trusted variant classification process, and reliable turnaround times.
We offer an extensive and flexible hereditary cancer testing menu, from Sanger to exome-based testing, for multiple cancer types, including tumor-type specific, and gene or variant specific options, so you can select the most appropriate test for your patient.
Genetic testing for hereditary cancer can provide actionable information that enables treatment guidance for a current cancer diagnosis or risk reduction for future cancers. This means that choosing the right test for the patient is important.
Our team of certified genetic counselors is available via email or phone to support healthcare providers through the genetic testing process. We provide you with tools for identifying at-risk patients, educational materials, and support in selecting the most beneficial test. Once testing is complete, we can assist you with the interpretation of test results and their implications for your patient and their family.
Test results are available in 8-10 days* for BRCA1/2 and in 2-3 weeks* for panels, allowing for quicker integration of genetic information into your patients’ care.
* Reporting times are estimated, but could be extended in situations outside GeneDx’s control.
We offer testing on several different specimen types including blood, buccal swabs, and cultured fibroblasts.
GeneDx has the ability to culture fibroblasts in house, making genetic testing for patients with certain hematological malignancies or a history of a bone marrow/stem cell transplant easier.
Buccal kits can be sent directly to patients for easy at-home specimen collection.
Family Medical History